Esperion Therapeutics reported $-55117000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amarin AMRN:US USD -5140000 64.82M
Amgen AMGN:US USD 2.14B 826M
Biogen BIIB:US USD 1.13B 76.7M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Cytokinetics CYTK:US USD -142310000 122.49M
Daiichi Sankyo 4568:JP JPY 39.46B 20.6B
Eli Lilly And LLY:US USD 1.45B 499.2M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
IONIS PHARMACEUT IONS:US USD -46992000 58.14M
Merk MRK:US USD 3.25B 696M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Moderna Inc MRNA:US USD 1.04B 1.15B
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Pfizer PFE:US USD 8.61B 1.3B
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
United Therapeutics UTHR:US USD 239.3M 123.3M